Unlike generic GLP-1 programs, PlexusDx personalizes your treatment plan by considering your unique metabolism, genetics, and health history
The abdominal complaints can be alleviated by starting at lower doses and slowly increasing
It belongs to a novel class of agents known as triple agonists , meaning it simultaneously activates three distinct hormone receptors: GLP-1 (glucagon-like peptide-1) stimulates insulin secretion, reduces appetite, and slows gastric emptying [7] [8] GIP (glucose-dependent insulinotropic polypeptide) enhances insulin release and may improve fat metabolism Glucagon receptor increases energy expenditure and promotes fat breakdown (lipolysis)
Whether the goal is improving blood sugar stability, reducing reliance on reactive eating, or achieving weight balance, GLP-1 peptide therapy can provide a valuable tool
The medications address the biological drivers of obesity (hormonal signaling, appetite regulation) but do not permanently rewire these systems